{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:55:39Z","timestamp":1794833739066,"version":"4.9.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":1096,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jpainsymman.2018.12.001","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T22:56:37Z","timestamp":1545260197000},"page":"635-645.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Safe and Appropriate Use of Methadone in Hospice and Palliative Care: Expert Consensus White Paper"],"prefix":"10.1016","volume":"57","author":[{"given":"Mary Lynn","family":"McPherson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellar P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-8675","authenticated-orcid":false,"given":"Akhila","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Paice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasey","family":"Malotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn Kashelle","family":"Lockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Wellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Salpeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina M.","family":"Bemben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Lapointe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2018.12.001_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-150-6-200903170-00103","article-title":"QTc interval screening in methadone treatment","volume":"150","author":"Krantz","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib2","first-page":"493","article-title":"Vital signs: risk for overdose from methadone used for pain relief - United States, 1999-2010","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib3","first-page":"321","article-title":"Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society","volume":"15","author":"Chou","year":"2014","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib4","first-page":"128","article-title":"Interindividual variability in the concentrations of albumin and alpha-1-acid glycoprotein in patients with renal or liver disease, newborns and healthy subjects: implications for binding of drugs","volume":"30","author":"Viani","year":"1992","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/clpt.1982.217","article-title":"Methadone plasma protein binding: alterations in cancer and displacement from alpha 1-acid glycoprotein","volume":"32","author":"Abramson","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1056-8719(00)00043-5","article-title":"Methadone: a review of its pharmacokinetic\/pharmacodynamic properties","volume":"42","author":"Garrido","year":"1999","journal-title":"J\u00a0Pharmacol Toxicol Methods"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/clpt.1981.34","article-title":"Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma","volume":"29","author":"Romach","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00003088-200746100-00002","article-title":"Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics","volume":"46","author":"Davis","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/clpt.1981.172","article-title":"Methadone disposition in patients with chronic liver disease","volume":"30","author":"Novick","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsat.2015.04.008","article-title":"Predictors of opioid-related death during methadone therapy","volume":"57","author":"Leece","year":"2015","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib11","doi-asserted-by":"crossref","first-page":"1700690","DOI":"10.1183\/13993003.00690-2017","article-title":"Prescription opioid use in advanced COPD: benefits, perils and controversies","volume":"49","author":"Smallwood","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00228-017-2278-3","article-title":"Adverse cardiac events associated with incident opioid drug use among older adults with COPD","volume":"73","author":"Vozoris","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1183\/13993003.01967-2015","article-title":"Incident opioid drug use and adverse respiratory outcomes among older adults with COPD","volume":"48","author":"Vozoris","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1586\/17476348.2016.1143776","article-title":"The need to address increasing opioid use in elderly COPD patients","volume":"10","author":"Vozoris","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5055\/jom.2005.0045","article-title":"Methadone-related deaths","volume":"1","author":"Webster","year":"2005","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1526-4637.2007.00343.x","article-title":"Sleep-disordered breathing and chronic opioid therapy","volume":"9","author":"Webster","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5055\/jom.2017.0385","article-title":"Looking both ways before crossing the street: assessing the benefits and risk of opioids in treating patients at risk of sleep -disordered breathing for pain and dyspnea","volume":"13","author":"Davis","year":"2017","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib18","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1378\/chest.128.3.1348","article-title":"Central sleep apnea in stable methadone maintenance treatment patients","volume":"128","author":"Wang","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5664\/jcsm.26751","article-title":"Central apnea during stage 3,4 sleep","volume":"3","author":"Berry","year":"2007","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","article-title":"Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study","volume":"174","author":"Abrahamsson","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jflm.2014.12.013","article-title":"Drug-related deaths between 2002 and 2013 with accent to methadone and benzodiazepines","volume":"31","author":"Petrushevska","year":"2015","journal-title":"J\u00a0Forensic Leg Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib22","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2010-2014","volume":"65","author":"Warner","year":"2016","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jflm.2016.01.016","article-title":"Therapeutic and recreational methadone cardiotoxicity","volume":"39","author":"Lusetti","year":"2016","journal-title":"J\u00a0Forensic Leg Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/jpm.2016.0411","article-title":"Methadone and corrected QT prolongation in pain and palliative care patients: a case-control study","volume":"20","author":"Juba","year":"2017","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00952990.2013.804525","article-title":"QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study","volume":"39","author":"Fareed","year":"2013","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1472-8206.2010.00871.x","article-title":"QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France","volume":"25","author":"Perrin-Terrin","year":"2011","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib27","first-page":"976","article-title":"Methadone safety guidelines: a new care delivery paradigm","volume":"15","author":"Katz","year":"2014","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib28","first-page":"CD008939","article-title":"QTc interval screening for cardiac risk in methadone treatment of opioid dependence","author":"Pani","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijcard.2018.04.076","article-title":"Assessment and interpretation of sleep disordered breathing severity in cardiology: clinical implications and perspectives","volume":"271","author":"Linz","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib30","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.chest.2018.03.052","article-title":"Servo-ventilation therapy for sleep-disordered breathing","volume":"153","author":"Somers","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2459\/JCM.0b013e32834033f2","article-title":"Cardiovascular-associated disease in an addicted population: an observation study","volume":"12","author":"Demarie","year":"2011","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0885-3924(03)00313-0","article-title":"Prolongation of the QT interval in palliative care patients","volume":"26","author":"Walker","year":"2003","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.md.0000085057.63483.9b","article-title":"Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors","volume":"82","author":"Zeltser","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-158-10-201305210-00008","article-title":"Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data","volume":"158","author":"Kao","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/2045125312469982","article-title":"Methadone, QTc interval prolongation and torsade de pointes: case reports offer the best understanding of this problem","volume":"3","author":"Vieweg","year":"2013","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fgene.2013.00024","article-title":"Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance","volume":"4","author":"Zanger","year":"2013","journal-title":"Front Genet"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1742-7843.2010.00628.x","article-title":"Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation","volume":"108","author":"Chang","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/chir.10303","article-title":"Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19","volume":"16","author":"Gerber","year":"2004","journal-title":"Chirality"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cpdd.137","article-title":"Drug interactions with methadone: time to revise the product label","volume":"3","author":"Greenblatt","year":"2014","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib40","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/ALN.0000000000000867","article-title":"Methadone pharmacogenetics: CYP2B6 polymorphisms determine plasma concentrations, clearance, and metabolism","volume":"123","author":"Kharasch","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jcph.1","article-title":"Role of cytochrome P4502B6 in methadone metabolism and clearance","volume":"53","author":"Kharasch","year":"2013","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/dmd.110.034504","article-title":"Cigarette smoke extract induces CYP2B6 through constitutive androstane receptor in hepatocytes","volume":"39","author":"Washio","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib43","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1345\/aph.1P759","article-title":"Methadone toxicity due to smoking cessation--a case report on the drug-drug interaction involving cytochrome P450 isoenzyme 1A2","volume":"45","author":"Wahawisan","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib44","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2217\/pgs.14.56","article-title":"Pharmacogenomics of methadone maintenance treatment","volume":"15","author":"Somogyi","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/tpj.2015.70","article-title":"Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations","volume":"16","author":"Fricke-Galindo","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib46","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/dmd.115.064352","article-title":"Differences in methadone metabolism by CYP2B6 variants","volume":"43","author":"Gadel","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib47","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/jpm.2014.0266","article-title":"The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report","volume":"18","author":"Salpeter","year":"2015","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib49","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1089\/jpm.2012.0612","article-title":"The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia","volume":"16","author":"Salpeter","year":"2013","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib50","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib51","first-page":"412","article-title":"Treatment of pain in methadone-maintained patients","volume":"67","author":"Scimeca","year":"2000","journal-title":"Mt\u00a0Sinai J Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bmjspcare-2016-001126","article-title":"Pain management strategies for patients on methadone maintenance therapy: a systematic review of the literature","volume":"7","author":"Taveros","year":"2016","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib54","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0885-3924(94)90203-8","article-title":"Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status","volume":"9","author":"Compton","year":"1994","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14740338.2015.979389","article-title":"Dual opioid therapy using methadone as a coanalgesic","volume":"14","author":"Reddy","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/jpm.2017.0157","article-title":"Improved pain control in terminally ill cancer patients by introducing low-dose oral methadone in addition to ongoing opioid treatment","volume":"21","author":"Furst","year":"2018","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib57","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1089\/jpm.2015.0525","article-title":"Methadone as a coanalgesic for palliative care cancer patients","volume":"19","author":"Courtemanche","year":"2016","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/jpm.2012.0335","article-title":"Addition of methadone to another opioid in the management of moderate to severe cancer pain: a case series","volume":"16","author":"Wallace","year":"2013","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/clpt.1988.159","article-title":"Sublingual absorption of selected opioid analgesics","volume":"44","author":"Weinberg","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib60","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/jpm.2006.0150","article-title":"Rational use of sublingual opioids in palliative medicine","volume":"10","author":"Reisfield","year":"2007","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib61","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1089\/jpm.2013.0522","article-title":"Effectiveness of the buccal mucosa route for methadone administration at the end of life","volume":"17","author":"Spaner","year":"2014","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib62","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2125.2004.02116.x","article-title":"Bioavailabilities of rectal and oral methadone in healthy subjects","volume":"58","author":"Dale","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/15360280802251199","article-title":"Conversion from parenteral to oral methadone","volume":"22","author":"Gonzalez-Barboteo","year":"2008","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0304-3959(03)00205-7","article-title":"QTc interval prolongation associated with intravenous methadone","volume":"105","author":"Kornick","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0304-3959(91)90179-2","article-title":"Local toxicity with subcutaneous methadone. Experience of two centers","volume":"45","author":"Bruera","year":"1991","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/J354v19n02_03","article-title":"Intermittent subcutaneous methadone administration in the management of cancer pain","volume":"19","author":"Centeno","year":"2005","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0885-3924(99)00020-2","article-title":"Subcutaneous methadone in terminally ill patients: manageable local toxicity","volume":"18","author":"Mathew","year":"1999","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib68","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/clpt.1985.237","article-title":"Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain","volume":"38","author":"Max","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/bja\/65.2.204","article-title":"Plasma concentrations of methadone during postoperative patient-controlled extradural analgesia","volume":"65","author":"Shir","year":"1990","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib70","first-page":"377","article-title":"Safe methadone induction and stabilization: report of an expert panel","volume":"7","author":"Baxter","year":"2013","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib71","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1360-0443.2002.00179.x","article-title":"An increase in overdose mortality during the first 2 weeks after\u00a0entering or re-entering methadone treatment in Amsterdam","volume":"97","author":"Buster","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1360-0443.2000.951778.x","article-title":"Deaths in methadone maintenance treatment in New South Wales, Australia 1990-1995","volume":"95","author":"Zador","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/09595230220139028","article-title":"Methadone-related deaths and\u00a0mortality rate during induction into methadone maintenance, New South Wales, 1996","volume":"21","author":"Zador","year":"2002","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib74","first-page":"1883","article-title":"Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen","volume":"22","author":"Barclay","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib75","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/jpm.2012.0263","article-title":"Screening for substance abuse and diversion in Virginia hospices","volume":"16","author":"Blackhall","year":"2013","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib76","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1089\/jpm.2015.0098","article-title":"Do palliative care clinics screen for substance abuse and diversion? Results of a national survey","volume":"18","author":"Tan","year":"2015","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib77","doi-asserted-by":"crossref","first-page":"123","DOI":"10.36076\/ppj.2011\/14\/123","article-title":"Urine drug testing in chronic pain","volume":"14","author":"Christo","year":"2011","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib78","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jat\/bku075","article-title":"False-positive interferences of common urine drug screen immunoassays: a review","volume":"38","author":"Saitman","year":"2014","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib79","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.4088\/JCP.10l06044yel","article-title":"False-positive methadone drug screens during quetiapine treatment","volume":"71","author":"Fischer","year":"2010","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib80","first-page":"269","article-title":"False-positive methadone urine drug screen in a patient treated with quetiapine","volume":"51","author":"Lasic","year":"2012","journal-title":"Acta Clin Croat"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib81","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/ajp.2007.164.1.172","article-title":"Quetiapine cross reactivity with urine methadone immunoassays","volume":"164","author":"Widschwendter","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib82","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/PEC.0b013e3181f05443","article-title":"Rapid urine drug screens: diphenhydramine and methadone cross-reactivity","volume":"26","author":"Rogers","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib83","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpainsymman.2012.02.023","article-title":"Frequency and predictors of patient deviation from prescribed opioids\u00a0and barriers to opioid pain management in patients with advanced cancer","volume":"45","author":"Nguyen","year":"2013","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib84","first-page":"935","article-title":"A\u00a0systematic review of prospective studies reporting adverse events of commonly used opioids for cancer-related pain: a call for the use of standardized outcome measures","volume":"16","author":"Oosten","year":"2015","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib85","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1634\/theoncologist.2014-0071","article-title":"Patterns of storage, use, and disposal of opioids among cancer outpatients","volume":"19","author":"Reddy","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbi.2006.12.009","article-title":"Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry\u2013do they comply with FDA recommendations?","volume":"168","author":"Hewitt","year":"2007","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib87","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1208\/s12248-009-9106-3","article-title":"Predicting drug-drug interactions: an FDA perspective","volume":"11","author":"Zhang","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib88","unstructured":"U.S. Food & Drug Administration. Drug development and\u00a0drug interactions: table of substrates, inhibitors and inducers. Available at: https:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/DrugInteractionsLabeling\/ucm093664.htm. Accessed April 12, 2017."},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib89","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1124\/dmd.108.021907","article-title":"Prediction of drug-drug interactions from in vitro induction data: application of the relative induction score approach using cryopreserved human hepatocytes","volume":"36","author":"Fahmi","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib90","unstructured":"Woosley RL, Heise CW, Romero KA. QT drugs lists.\u00a0Available at: www.crediblemeds.org. Accessed May 16, 2017."},{"key":"10.1016\/j.jpainsymman.2018.12.001_bib91","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/01.aids.0000183628.20041.f2","article-title":"Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction","volume":"19","author":"Friedland","year":"2005","journal-title":"AIDS"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539241831114X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539241831114X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:05:27Z","timestamp":1775322327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088539241831114X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S088539241831114X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2018.12.001","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safe and Appropriate Use of Methadone in Hospice and Palliative Care: Expert Consensus White Paper","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2018.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}